Saizen® Solution for Injection Immunogenicity Study.



Status:Archived
Conditions:Endocrine
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:October 2010

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Phase IIIb, Open-label, Single-arm, Multicenter Study to Assess the Immunogenicity of the Recombinant-Human Growth Hormone (r-hGh) Liquid Multidose Formulation (Saizen® Solution for Injection) When Administered to Male and Female Adults With Documented Growth Hormone Deficiency (GHD)


To assess the immunogenicity of Saizen solution for injection in adult subjects with
documented Growth Hormone Deficiency (GHD).



We found this trial at
1
site
Clinical Trial Facility
Boston, Massachusetts
?
mi
from
Boston, MA
Click here to add this to my saved trials